Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Basic principles of the antisense strategy].

Roxana Georgiana Tauşer1, Ortansa Stoica

  • 1Disciplina de Chimie Farmaceutică, Facultatea de Farmacie, Universitatea de Medicină şi Farmacie Gr.T. Popa Iaşi.

Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi
|February 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent Biomedical Approaches for Chitosan Based Materials as Drug Delivery Nanocarriers.

Pharmaceutics·2021
Same author

[Retrospective clinical and laboratory study of the toxocariasis cases hospitalised between 2005 and 2008].

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi·2010
Same author

[Retroprospective epidemiological study of toxocariasis cases hospitalized between 2005-2008].

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi·2010
Same author

[Heart insufficiency in elderly--new dimensions of the problem].

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi·2009
Same author

[Iatrogeny and the elderly].

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi·2008
Same author

[Clinical, epidemiological and cytogenetic studies on 221 patients with Down syndrome].

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi·2007
Same journal

Antioxidant Activity of Essential Oil From Carum Carvi L. Cultivated in North-Eastern Romania.

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi·2018
Same journal

Assessment of In Vitro Antioxidant activity of Some New Ferulic Acid Derivatives.

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi·2018
Same journal

Fast RP-HPLC Method for the Determination of Bisoprolol.

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi·2018
Same journal

In Vitro Dissolution Studies of Amiodarone Hydrochloride From Hydroxy-Propyl-β-Cyclodextrin/Amiodarone Inclusion Complex Formulated Into Modified-Release Tablets.

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi·2018
Same journal

Esthetic Rehabilitation Through CAD/CAM Technology - Case Report.

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi·2018
Same journal

Correlation Among Chronological Age, Dental Age and Cervical Vertebrae Maturity in Romanian Subjects.

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi·2018
See all related articles

Antisense oligonucleotides (OGN) selectively inhibit mutant gene expression by targeting DNA or RNA. Design focuses on enhancing OGN affinity and stability for therapeutic applications.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Context:

  • The antisense strategy utilizes oligodeoxynucleotides (OGN) for specific gene silencing.
  • This approach targets mutant gene expression at the DNA or RNA level.

Purpose:

  • To explore the molecular mechanisms of antisense oligonucleotides.
  • To outline the applications of antisense strategy in therapeutic agent design and disease detection.
  • To highlight key design considerations for effective antisense oligonucleotides.

Summary:

  • Antisense oligonucleotides (OGN) are designed to hybridize selectively with target DNA or RNA, inhibiting gene expression.
  • Mechanisms include splicing inhibition, 5'-capping and 3'-polyadenylation interference, RNase H activation, and leveraging small interfering RNA and ribozymes.

Related Experiment Videos

  • Applications span rational drug design, target validation, and in vivo detection of pathological gene expression.

    • Impact:

    • Advances in antisense technology enable the development of potent and selective therapeutic agents.
    • Improved OGN design enhances target RNA affinity and resistance to degradation, crucial for clinical efficacy.